Aurora expands medical cannabis offerings in australia with the launch of indimed tempo 22

Nasdaq | tsx: acb   canada's largest medical cannabis company adds two new cultivars to popular brand portfolio in the australian market edmonton, ab , june 5, 2025 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb), the canadian-based leading global medical cannabis company, has expanded their popular indimed brand with the launch of indimed tempo 22, available through the company's subsidiary, medreleaf australia. with the same consistent quality and reliable supply, this new 22% thc potency creates a greater range of treatment options available to prescribers.
ACB Ratings Summary
ACB Quant Ranking